Small toy figures are seen in front of a Covid-19 Vaccine logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
MOSCOW: Russia has completed clinical trials of a second potential vaccine against COVID-19, developed by Siberia's Vector Institute, the RIA news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Wednesday.
The institute completed early-stage human trials, known as Phase II, earlier this month.
